AusPAR: Ipilimumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR Ipilimumab [PDF, 1.03 MB]

AusPAR Ipilimumab [Word, 1.16 MB]

Attachment: Product Information: Ipilimumab (rch) [PDF, 434.05 KB]

Attachment: Product Information: Ipilimumab (rch) [Word, 149.21 KB]

Attachment: Extract from Clinical Evaluation Report: Ipilimumab (rch) [PDF, 3.95 MB]

Attachment: Extract from Clinical Evaluation Report: Ipilimumab (rch) [Word, 8.39 MB]

Device/Product Name

Yervoy/ Winglore

Active ingredients

Ipilimumab (rch)

AusPAR Date

6 February 2017

Published

23 February 2017

Submission Number

PM-2013-04125-1-4

Submission Type

Major variation (new indication)

Decision

Approved